Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Rheumatoid Arthritis – Unmet Need – Unmet Need – TNFi-Refractory Rheumatoid Arthritis (US/EU)
Rheumatoid arthritis (RA) patients who are refractory to one or more tumor necrosis factor (TNF)-alpha inhibitors are generally prescribed a non-TNF-targeted therapy (e.g., Bristol Myers Squibb’s…
Prostate Cancer – Unmet Need – Unmet Need – Metastatic Hormone-Sensitive Prostate Cancer (US/EU)
Prostate cancer is the second-most-prevalent cancer in men, significantly impacting male mortality rates. Hormonal therapy is a cornerstone of drug treatment for all stages of prostate cancer…
Dry and Wet Age-Related Macular Degeneration – Unmet Need – Unmet Need – Geographic Atrophy (US/EU)
Geographic atrophy (GA) is an advanced stage of age-related macular degeneration characterized by the progressive and irreversible degeneration of retinal tissue, including photoreceptors. This…
Major Depressive Disorder (DSM-V) – Unmet Need – Unmet Need – Treatment-Resistant Depression (US/EU)
Major depressive disorder (MDD) is typically treated with psychotherapy, pharmacotherapy, or a combination of the two. The MDD therapy market is highly genericized; for patients experiencing…
Hemophilia B – Unmet Need – Unmet Need – Severe Noninhibitor Hemophilia B (US/EU)
Hemophilia B is a genetic disorder caused by a deficiency in clotting factor IX (FIX). Individuals with this condition experience prolonged bleeding. Prescribing options include factor balancing…
Schizophrenia – Unmet Need – Unmet Need – Cognitive Impairment Associated with Schizophrenia (US/EU)
CIAS (e.g., impaired attention / vigilance, memory, and/or executive function) negatively impacts patients’ daily activities, occupational and social functioning, and adherence to antipsychotic…